{
  "EBV": {
    "EBER-ISH Staining": "EBER-ISH positive; detects EBV RNA; diagnostic criteria; visualizes virus genetic material; differentiates EBV-positive cancer.",
    "Lymphoepithelioma-like Histology": "EBV-positive; lymphoepithelioma-like carcinoma; large sheets; syncytial clusters; undifferentiated cells; prominent lymphoid infiltration; no glandular formation; non-keratinizing; vesicular nuclei; prominent nucleoli; desmoplastic reaction.",
    "DNA Methylation": "Hypermethylated profile; loss of normal architecture; cellular atypia; uncontrolled proliferation; higher cell density; disorganized growth; loss of differentiation; primitive cell appearance; condensed or irregular nuclei.",
    "High frequency of PIK3CA mutations": "High mitotic rates; atypical gland formation; cellular pleomorphism; increased angiogenesis; altered tumor borders; stromal fibrosis or desmoplastic reaction.",
    "Rare TP53 mutations": "Regular tissue morphology; lower cellular atypia; lower mitotic rates; potential senescence markers; normal apoptotic rates.",
    "High frequency of ARID1A mutations": "Prominent intra-tumoral lymphocytes; loss of ARID1A staining; detected by IHC; variable tumor morphology; associated with cellular pleomorphism, high mitotic activity, aggressive growth pattern.",
    "9p24.1 amplifications": "9p24.1 amplification; PD-L1 and PD-L2 overexpression; increased TILs; non-keratinizing morphology; Reed-Sternberg cells in lymphoma; potential response to checkpoint blockade.",
    "DNA CpG hypermethylation": "Increased proliferation; high mitotic index; infiltrative tumor borders; cellular atypia; nuclear irregularity; loss of p16^INK4a expression on IHC.",
    "EBV-encoded miRNAs": "Lymphoepithelioma-like features; dense lymphoid infiltrates; variable tumor cell differentiation; prominent inflammation; EBER-positive staining on in situ hybridization.",
    "Tumor Infiltrating Lymphocytes": "Tumor-infiltrating lymphocytes; dispersed or clustered; infiltrating between cells or stromal; indicative of immune response.",
    "Intraepithelial Lymphocytosis": "Intraepithelial lymphocytes; small, round; dense nuclei; disrupts architecture; associated with neoplastic epithelium; stromal lymphoplasmacytic infiltration.",
    "Stromal Lymphoplasmacytic Infiltration": "Lymphocytes in stroma; plasma cells present; small cells with large nuclei; abundant basophilic cytoplasm; interspersed infiltration; reactive changes; possible fibrosis or edema.",
    "Syncytial trabecular pattern": "Syncytial trabecular pattern; nested growth; cord-like structures; indistinct cell borders; interconnected net-like structure.",
    "Increased TIL Infiltration": "Densely packed stromal lymphocytes; high nucleus-to-cytoplasm ratio; lymphocyte aggregates; tertiary lymphoid structures; sign of immune response.",
    "Higher Levels of CD4, CD8 T Cells and T Regulatory Cells": "CD4+ in periphery; CD4 stain highlighted; CD8+ within tumor; CD8 stain highlighted; Tregs by FOXP3 stain; suppress immune response.",
    "High levels of T cell activation": "High T cell activation; lymphoid aggregates; larger T cells; abundant cytoplasm; prominent nucleoli; CD69, HLA-DR, OX40, ICOS, Ki-67 expression.",
    "Higher Levels of Immune Checkpoint Markers": "PD-1 on T cells; PD-L1 on tumor/immune cells; CTLA-4 in lymphoid aggregates/invasive margins; LAG-3 on T cells; TIM-3 on T/innate immune cells.",
    "Higher expression of anti-tumor immunity factors": "Increased membrane staining; immune cell marker staining; dense immune stromal infiltration; organized lymphoid structures; associated inflammatory reaction.",
    "Lace-like Pattern": "Lace-like pattern; irregularly anastomosing tubules and cords; complex interconnected network; irregular net-like structure.",
    "Lymphoid Stroma": "Lymphoid stroma infiltration; \u201clace-like\u201d pattern; irregular tubules and cords; immune component in microenvironment; variable lymphoid infiltration.",
    "Neoplastic Epithelium": "Neoplastic epithelium; dysplasia; increased nuclear size; hyperchromasia; prominent nucleoli; high nuclear-to-cytoplasmic ratio; loss of differentiation; irregular glands or sheets.",
    "Invasion into the Submucosa": "Invasion into submucosa; scattered cells to clusters; neoplastic cells breach muscularis mucosae; lymphocytic response around cancer cells.",
    "Low Rate of Lymph Node Metastasis": "Low lymph node metastasis; regional lymph nodes with few or no cancer cells; disrupted lymph node architecture; pattern of replacement or expansion.",
    "Poor Differentiation": "Poorly differentiated adenocarcinomas; lacks specialized features; aggressive tumor; unformed glandular structures; infiltrating lymphoid stroma.",
    "Epithelial Markers": "Epithelial markers positive; CK7 expression reduced; confirms epithelial origin; differentiates EBVaGC from EBV-negative cancers.",
    "Ulcered or saucer-like tumor": "Central necrosis; ulceration with epithelial loss; robust inflammatory infiltrate; reactive cellular changes; marginal roll at ulcer edges; increased vascularity; surrounding fibrosis."
  },
  "others": {
    "Genomic Instability": "Activated RAS signaling; contributes to genomic instability; induces DNA damage; interferes with chromosome segregation; exacerbates CIN phenotype.",
    "Increased Mitotic Activity": "Increased mitotic rate; atypical mitotic figures; abnormal mitoses; high cellular proliferation.",
    "High Mitotic Index": "High number of mitotic cells; atypical mitoses; irregular mitotic figures; rapid tumor growth; increased metastasis likelihood.",
    "Nuclear Pleomorphism": "Variation in nuclear size and shape; nuclei size disparity; irregular nuclear shapes; oval to highly irregular forms.",
    "Hyperchromasia": "Nuclei appear darker; excess DNA content.",
    "Irregular Nuclear Contours": "Uneven nuclear borders; indented nuclear contours.",
    "Prominent Nucleoli": "Prominent nucleoli; increased number of nucleoli; sign of heightened protein synthesis; rapid cell division indicator.",
    "Chromatin Clumping": "Irregular chromatin clumping; patchy nuclear appearance.",
    "Multipolar spindles": "Multipolar spindles; asymmetric nuclear division; uneven genetic material distribution; cells with abnormal nuclear shapes and sizes.",
    "Tumor Heterogeneity": "CIN-induced genetic heterogeneity; RAS-driven proliferation of diverse cells; increased tumor complexity; potential influence on drug resistance; enhancement of metastatic potential.",
    "Increased TP53 Mutations": "TP53 enrichment in high-CIN tumors; link to mitotic stress; TP53 malfunctions; increased mitotic figures in histology; atypical nuclear features; increased nuclear size; irregular nuclear contours; hyperchromasia; prominent nucleoli; genomic instability; altered cell cycle regulation; variety of cell types; abnormal tumor structures.",
    "Cell Proliferation": "RAS pathway activation; promotes cell division; genomic instability in CIN; proliferation of abnormal cells; contributes to tumor growth; aids tumor progression.",
    "Poorly Differentiated Tumor Cells": "High-grade dedifferentiation; higher likelihood of metastasis.",
    "Lymphovascular Invasion": "Tumor cells in lymphatic vessels; tumor cells in blood vessels; direct indication of metastasis.",
    "Perineural Invasion": "Tumor cells invading perineural space; association with aggressive tumors; increased risk of metastasis.",
    "Tumor Budding": "Small clusters of cancer cells at invasive front; individual cells at invasive front; sign of aggressive tumor phenotype; correlated with metastasis.",
    "Desmoplasia": "Pronounced desmoplastic reaction; growth of fibrous tissue; connective tissue increase; association with aggressive tumors.",
    "Depth of Invasion": "Deeper gastric wall invasion; invasion into subserosal layer; invasion beyond subserosa; higher metastasis risk.",
    "Correlated Lauren's Intestinal Type": "Well-formed glandular structures; intestinal epithelium resemblance; chronic gastritis initiation; progression to atrophy; intestinal metaplasia; dysplasia; carcinoma development; common in high-incidence regions; environmental factor association; diet-related; Helicobacter pylori infection.",
    "Increased PIK3CA mutations": "PIK3CA enrichment in low-CIN tumors; increased cell growth and proliferation; high mitotic index; dense cellular arrangement; increased microvessel density in tumor stroma; variable cellular morphology and architecture; fewer apoptotic cells than expected; contributes to tumor cell invasion; aids in metastasis.",
    "Reduced or Aberrant Staining for E-cadherin": "Immunohistochemistry (IHC) for E-cadherin; reduced staining; absent staining; areas with CDH1 mutations; loss of protein expression.",
    "Signet Ring Cells": "Loss of E-cadherin function; CDH1 mutations; presence of signet ring cells; large vacuole in cells; nucleus at periphery; signet ring-like appearance; indicative of poor prognosis.",
    "Loss of Cell Cohesion": "Mutations in CDH1; loss of E-cadherin function; reduced intercellular adhesion; diffuse infiltration of gastric wall; isolated tumor cells; small clusters of cells; lack of glandular structures; characteristic of diffuse-type gastric cancer; Lauren's classification.",
    "Altered Cell Adhesion": "Claudin-18 role in cell-cell adhesion; alterations affect epithelial integrity; observed gaps between cells; loss of 'honeycomb' pattern in gastric epithelium.",
    "Abnormal Cell Shapes and Arrangement": "RHO gene mutations; changes in cell morphology; altered actin cytoskeleton; elongated cells; spindle-shaped cells; epithelial-to-mesenchymal transition (EMT) indication; observed in GS subtype of GC.",
    "Dysregulated Actin Cytoskeleton": "RHO gene mutations; actin cytoskeleton alterations; affects cell shape and motility; not observable in H&E staining; irregular tumor cell arrangement; visualized with cytoskeletal markers; IHC; fluorescent stains."
  }
}